Allos Therapeutics Reports Third Quarter 2007 Financi... (1 study in patients with advanced solid ...)

Allos Therapeutics Reports Third Quarter 2007 Financial Results

Date:11/5/2007

1 study in patients with advanced solid tumors in the fourth quarter of 2007. For additional information, please visit the Company's website at http://www.allos.com.

Safe Harbor Statement

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements concerning the Company's projected timelines for the performance of the 65 patient safety assessment and completion of enrollment of the PROPEL trial, the Company's intent to initiate a Phase 2 study of PDX in patients with NSCLC, and other statements which are other than statements of historical facts. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expects," "intends," "plans," anticipates," "believes," "estimates," "predicts," "projects," "potential," "continue," and other similar terminology or the negative of these terms, but their absence does not mean that a particular statement is not forward-looking. Such forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that may cause actual results to differ materially from those anticipated by the forward-looking statements. These risks and uncertainties include, among others: that the Company may experience difficulties or delays in the initiation, progress or completion of its clinical trials, whether caused by competition, adverse events, investigative site initiation rates, patient enrollment rates, regulatory issues or other factors; and that the Company's clinical trials may not demonstrate the safety and efficacy of the Company's product candidates in their target indications. Even if clinical trials demonstrate the safety and efficacy of the Company's product candidates, regulatory authorities may not approve such product candidates, the
'/>"/>

SOURCE Allos Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7
Related medicine news :

1. Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference
2. Prime Therapeutics Receives TIPPS Certification
3. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
4. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
5. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
6. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
7. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
8. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
9. Prime Therapeutics Announces URAC Accreditation
10. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
11. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting

Post Your Comments:

(Date:5/25/2013)... (HealthDay News) -- Many viruses and parasites that affect ... -- a bacteria-borne illness than can result in liver ... parks, according to a veterinarian. These germs ... the air, said Dr. Susan Nelson, a clinical associate ... of these serious diseases can be fatal, even with ...

(Date:5/25/2013)... 2013 Providing patients with their best weight ... of weight management professionals. But, aside from educating patients on ... Doc’s hCG diets also provide patients, who have ... like bullying, more control over their lives by achieving their ... the underlying factors of weight gain derived from earlier abuse, ...

(Date:5/25/2013)... New York,NY (PRWEB) May 25, 2013 ... SizeItUp officially declared the integration of the 2012 ... Lamborghini Aventador is the latest entrant in the list ... Designed intelligently, the vehicle is all set to thrill ... with vicious acceleration power and spectacular looks, the 2012 ...

(Date:5/25/2013)... Vancouver, BC (PRWEB) May 25, 2013 ... of the most beautiful and powerful women that ever ... was felt by some of the most powerful men ... used many beauty remedies to keep her skin glowing ... treatments made with bees- wax, maringa oil and cyprus ...

(Date:5/25/2013)... 25, 2013 For college students, ... week. Increasingly, they are turning to prescription stimulants ... study. For more on this, go to ... facility, warns that students who pick up Adderall, ... risk for developing a physical and psychological dependency. ...

Breaking Medicine News(10 mins):Health News:Hidden Dangers Dog Dog Parks 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3 Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3 Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2

[0] Hidden Dangers Dog Dog Parks [0] hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain [0] Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador [0] The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician [0] Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals

... America and Merrill Lynch 2009 Health Care Conference on May ... May 19 -SAN DIEGO, May 6 Gen-Probe Incorporated (Nasdaq: ... present at the Bank of America and Merrill Lynch 2009 ... at approximately 9:20 a.m. Eastern time, and at the Deutsche ...

... Infotrieve, Inc. ( www.infotrieve.com ), the ... revolutionary software solution Content SCM(R) ... Science or Technology Service category of the 2009 CODiE ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20080709/LAW008LOGO ...

... the 125,000-member Indiana American Legion today challenged the Indiana ... act plainly on behalf of the youngsters at the ... called on legislators to "not use the current budget ... plans announced by the Indiana State Department of Health, ...

... HOUSTON, May 6 Carriage Services, Inc. (NYSE: CSV ) today announced results for the first quarter ended March 31, 2009. ... Selected Financial Results , (amounts in millions, except per share amounts) , , ... Q1 Q1, ... 2009 Change, ...

... For Using A Knowledgeable Travel Advisor As The Swine ... The sudden outbreak of the H1N1 virus, more ... by surprise, causing opinions to become unsubstantiated rumors over ... luxury travel network, Virtuoso, has reached out to its ...

... First Quarter Highlights:- Revenue gained 7.5% to $187 ... 58.7% compared to Q1 2008, rising to $5.9 ... in client census and rate combined with increased ... from operations totaled $7.8 million- Sale of NET ...

Gen-Probe to Webcast Two Upcoming Investor Presentations Infotrieve's Content SCM(R) Wins 2009 CODiE Award Legion Demands 'Courage' From Legislators in Battle Over Children's Home Carriage Services Announces First Quarter 2009 Results Virtuoso(R) Affirms Travel Amidst H1N1 Flu Scare Providence Service Corporation Announces Record Revenues and Earnings in the First Quarter of 2009

(Date:5/24/2013)... Sinovac Biotech Ltd. (NASDAQ: SVA ... China , announced that Sinovac ... obtained the Certificate of Good Manufacturing Practices for ... and Food Administration (CFDA) for its proprietary vaccines, ... Changping filing and packaging facility. The GMP certificate ...

(Date:5/23/2013)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ) ... Life Science Firm of the Year by the Tech Council ... at the TCM,s 25 th Annual Tech Awards Celebration ... Awards Celebration recognizes the leaders and innovators in the technology ... and the surrounding regions. "We are deeply ...

(Date:5/23/2013)... , May 23, 2013 Haemonetics Corporation (NYSE: ... , CFO & EVP-Business Development, will present at The Deutsche ... Boston, MA on May 29, 2013 ... ) The public may access Mr. Lindop,s ... About Haemonetics Haemonetics (NYSE: HAE ...

Breaking Medicine Technology:Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2 Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3 Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2

[0] Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines [0] Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland [0] Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference

... CHICAGO, Jan. 19, 2012 According to Marcia Crosse (Director, ... its mission to protect American health has been compromised. In ... on GAO,s High-Risk List, she says : ... in protecting the health of all Americans. FDA,s role is ...

... 2012 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... of 9,500,000 shares of its common stock at a ... gross proceeds to Neurocrine from this offering, before deducting ... by Neurocrine, are expected to be approximately $77 million. ...

Cached Medicine Technology:Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight? 2 Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight? 3 Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight? 4 Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock 2 Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock 3

Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight?Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock

High temperature loop tip cautery....

High temp cauteries, fine tip micro....

Thru cut kerrison style punch 30 deg, 2.75 X 1.4 mm cut, 110 working length....

6 mm, 45 degree upwards, detachable....

Medicine Products:

High Temperature Cauteries High Temp Cauteries Kerrison style punch Ferris-Smith Kerrison punches